Study of Dutogliptin in Combination With Filgrastim in Post-Myocardial Infarction
Trial ID or NCT#
NCT03486080
Status
NOT RECRUITING
Purpose
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Safety and Efficacy Study of Dutogliptin in Combination with Filgrastim in Early Recovery Post-Myocardial Infarction
Official Title
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Safety and Efficacy Study of Dutogliptin in Combination With Filgrastim in Early Recovery Post-Myocardial Infarction
Eligibility Criteria
Ages Eligible for Study: 18 Years to 85 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: Yes
Exclusion Criteria:
Investigator(s)
Contact us to find out if this trial is right for you.
Contact
Melissa Pozun
916-533-1603
View on